Table 2 Antifungal susceptibility testing results (ATB Fungus 3) of 378 Candida [n (%)]
|  | C.albicans (n = 134) | C.parapsilosis (n = 86) | C.tropicalis (n = 67) | C.glabrata (n = 47) | C.krusei (n = 5) | C.sake (n = 8) | C.guilliermondii (n = 19) | Other Candida spp. (n = 12) | Total(n = 378) |
|---|---|---|---|---|---|---|---|---|---|
Fluconazole | |||||||||
S | 126 (94) | 77(89.5) | 35 (52.2) | 0 (0) | 0 (0) | 8(100) | 13 (68.4) | 9 (75.0) | 268 (70.9) |
SDD | 1 (0.8) | 6 (7.0) | 3 (4.5) | 44(93.6) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 54 (14.3) |
R | 7 (5.2) | 3 (3.5) | 29 (43.3) | 3 (6.4) | 5 (100) | 0 (0) | 6 (31.6) | 3 (25.0) | 56 (14.8) |
Itraconazole | |||||||||
S | 110 (82.1) | 75 (87.2) | 25 (37.3) | 0 (0) | 0 (0) | 8 (100) | 6 (31.6) | 9 (75.0) | 233 (61.6) |
SDD | 6 (4.5) | 7 (8.1) | 4 (6.0) | 40 (85.1) | 2 (40.0) | 0 (0) | 7 (36.8) | 0 (0) | 66 (17.5) |
R | 18 (13.4) | 4 (4.7) | 38 (56.7) | 7 (14.9) | 3 (60.0) | 0 (0) | 6 (31.6) | 3 (25.0) | 79 (20.9) |
Voriconazole | |||||||||
S | 125 (93.3) | 79 (91.9) | 41 (61.2) | 45 (95.8) | 4 (80.0) | 8 (100) | 12 (63.2) | 11 (91.7) | 325 (86.0) |
SDD | 0 (0) | 2 (2.3) | 2 (3.0) | 1 (2.1) | 1 (2.0) | 0 (0) | 3 (15.8) | 0 (0) | 9 (2.4) |
R | 9 (6.7) | 5 (5.8) | 24 (35.8) | 1 (2.1) | 0 (0) | 0 (0) | 4 (21.0) | 1 (8.3) | 44 (11.6) |
Amphotericin B | |||||||||
S | 133 (99.3) | 83 (96.5) | 67 (100) | 47 (100) | 5 (100) | 8 (100) | 18 (94.7) | 11 (91.7) | 372 (98.4) |
R | 1 (0.7) | 3 (3.5) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (5.3) | 1 (8.3) | 6 (1.6) |
Flucytosine | |||||||||
S | 132 (98.5) | 85 (98.8) | 65 (97.0) | 46 (97.9) | 1 (20.0) | 8 (100) | 9 (47.4) | 12 (100) | 358 (94.7) |
R | 2 (1.5) | 1 (1.2) | 2 (3.0) | 1 (2.1) | 4 (80.0) | 0 (0) | 10 (52.6) | 0 (0) | 20 (5.3) |